Understand the source comparison
FDA Guidelines: Research Use vs Human Consumption
The FDA draws a sharp line between research chemicals and drugs intended for human consumption. And that line is defined by intended use, not chemical structure. Selank Amidate's legal status hinges on how it's marketed and what claims are made about its effec
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The FDA draws a sharp line between research chemicals and drugs intended for human consumption. And that line is defined by intended use, not chemical structure. Selank Amidate's legal status hinges on how it's marketed and what claims are made about its effects. If a supplier labels it for research and refrains from therapeutic claims, it remains outside FDA drug regulation. If that same supplier markets it as a cognitive enhancer, anxiolytic, or neuroprotective agent for human use, it becomes an unapproved new drug subject to immediate enforcement action.
- FDA Compliance Policy Guide Sec. 400.400 explicitly addresses research chemicals: substances sold for laboratory research are not subject to the pre-market approval requirements that govern drugs. Provided they are not represented for clinical use. This creates the legal framework within which Selank Amidate operates. Suppliers must label products clearly, avoid therapeutic language in marketing materials, and refrain from providing dosing instructions, administration protocols, or health benefit claims. Violating any of these constraints converts a legal research product into an illegal unapproved drug.
- The penalties for misbranding research peptides as therapeutic agents are severe. FDA Warning Letters issued to peptide suppliers in recent years consistently cite two violations: marketing unapproved drugs with disease claims, and failure to include adequate directions for use (which is impossible for unapproved drugs because no legal use exists). Companies receiving Warning Letters face product seizure, injunctions, and in cases of continued non-compliance, criminal prosecution. For individual purchasers, the risk is different. Possession of research peptides for personal use exists in a regulatory gray area, but using them for self-administration constitutes off-label use of an unapproved drug, which carries both legal and health risks.
- Real Peptides operates under a research-only model specifically to maintain compliance with these guidelines. We do not provide dosing protocols, we do not make health claims, and we do not market peptides for human consumption. Our customers are research institutions, academic labs, and scientists conducting preclinical studies. Contexts where Selank Amidate legality is clear and unambiguous. This is the standard the FDA expects, and it's the standard we maintain across our full peptide collection.
- The concept of "off-label prescribing" does not apply to research peptides. Off-label prescribing is a legal practice in which licensed physicians prescribe FDA-approved drugs for unapproved indications. It requires that the drug has passed FDA approval for at least one indication. Selank Amidate has zero FDA-approved indications, which means no physician in the United States can legally prescribe it for any therapeutic purpose. Claiming that a doctor can prescribe research peptides off-label is a fundamental misunderstanding of both FDA drug law and medical prescribing authority.